A rat model of spontaneous myopathy and malignant hyperthermia

American Journal of Pathology

Volumn 152, Issue 4, 1998, Pages 1099-1103

  Gonzalez, Luis E ^a   Meléndez Vásquez, Carmen V ^a   Gregson, Norman A ^a   File, Sandra E ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HALOTHANE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENERAL ANESTHESIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INHALATIONAL DRUG ADMINISTRATION; MALIGNANT HYPERTHERMIA; MICROSCOPY; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HALOTHANE; IMMUNOHISTOCHEMISTRY; MALIGNANT HYPERTHERMIA; MICROSCOPY, FLUORESCENCE; MUSCLE, SKELETAL; MUSCULAR DISEASES; RATS; RATS, INBRED LEW;

EID: 2642708405     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Britt BA, Kalow W: Malignant hyperthermia: a statistical review. Can Anaesth Soc J 1970, 17:293-315
2. MacLennan DH, Phillips MS: Malignant hyperthermia. Science 1992, 256:789-794
3. Issacs H, Barlow MB: Malignant hyperpyrexia during anaesthesia: possible association with subclinical myopathy. Br Med J 1970, 1:275
4. Eng GD, Epstein BS, Engel WK, McKay DW, McKay R: Malignant hyperthermia and central core disease in a child with congenital dislocating hips. Arch Neurol 1978, 35:189-197
5. Henderson WAV: Succinylcholine induced cardiac arrest in unsuspected Duchenne muscular dystrophy. Can Anaesth Soc J 1984, 31:444-446
6. Brownell AK: Malignant hyperthermia: relationship to other diseases. Br J Anaesth 1988, 60:303-308
7. Jones EW, Nelson TE, Anderson IL, Kerr DD, Burnap TK: Malignant hyperthermia of swine. Anesthesiology 1972, 36:42-51
8. Nelson TE, Jones EW, Henrickson RL, Falk SN, Kerr DD: Porcine malignant hyperthermia: observations on the occurrence of pale, soft, exudative musculature among susceptible pigs. Am J Vet Res 1974, 35:347-350
9. Kirmayer AH, Klide AM, Purvance JE: Malignant hyperthermia in a dog: case report and review of the syndrome. J Am Vet Med Assoc 1984, 185:978-982
10. De Jong RH, Heavner JE, Amory DW: Malignant hyperpyrexia in the cat. Anesthesiology 1974, 41:608-609
11. Manley SV, Kelly AB, Hodgson D: Malignant hyperthermia like-reaction in three anesthetized horses. J Am Vet Med Assoc 1983, 183: 83-90
12. Cawley GD, Bradley R: Presumed congenital myodegeneration in a calf. Vet Rec 1979, 105:398-399
13. Citino SB, Bush M, Phillips LG: Dystocia and fatal hyperthermic episode in a giraffe. J Am Vet Med Assoc 1984, 185:1440-1442
14. Gonzalez LE, File SE: A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J Neurosci 1997, 17:1505-1511
15. Bancroff JD, Cook H: Manual of Histological Techniques. Edinburgh, Churchill Livingstone, 1984, pp 18-38
16. Muinos PA, Orteils MA, Sanchez G, Carrasco MS: A case of malignant hyperthermia without hyperthermia. Rev Esp Anestesiol Reanim 1995, 42:436
17. Denborough MA, Ebeling P, King JO, Zapf P: Myopathy and malignant hyperpyrexia. Lancet 1970, 1:1138-1140
18. Ellis FR, Keaney NP, Harriman DGF: Histopathological and neuropharmacological aspects of malignant hyperpyrexia. Proc R Soc Med 1973, 66:66-67
19. Harriman DF, Summer DW, Ellis FR: Malignant hyperpyrexia myopathy. Q J Med 1973, 42:639-664
20. Ranklev E, Henriksson KG, Flectcher R, Germundsson K, Oldfors, A, Kalimo, H: Clinical and muscle biopsy findings in malignant hyperthermia susceptibility. Acta Neurol Scand 1986, 74:452-459
21. Heiman-Patterson TD, Rosenberg H, Fletcher JE, Tahmoush AJ: Halothane-caffeine contracture testing in neuromuscular disease. Muscle Nerve 1988, 11:453-457
22. Wappler F, Roewer N, Lenzen C, Kochling A, Scholz J, Steinfath M, Schulteam Esch J: High-purity ryanodine and 9,21-dehydroryanodine for in vitro diagnosis of malignant hyperthermia in man. Br J Anaesth 1994, 72:240-242
23. Wedel DJ, Nelson TE: Malignant hyperthermia-diagnostic dilemma: false-negative contracture responses with halothane and caffeine alone. Anesth Analg 1994, 78:787-792
24. Bendixen D, Poulsen TD, Knudsen F, Nielsen J, Ording H: Clinical variability of possible malignant hyperthermia as revealed by two cases. Acta Anaesthesiol Belg 1994, 45:93-98
25. MacLennan DH: Discordance between phenotype and genotype in malignant hyperthermia. Curr Opin Neurol 1995, 8:397-401
26. Lopez JR, Perez C, Linares N, Allen P, Terzic A: Hypersensitive response of malignant hyperthermia-susceptible skeletal muscle to inositol 1,4,5-triphosphate induced release of calcium. Naunyn-Schmiedebergs Arch Pharmacol 1995, 352:442-446
27. Ryan JF, Tedeschi LG: Sudden unexplained death in a patient with a family history of malignant hyperthermia. J Clin Anesth 1997, 9:66-68
28. Calore EE, Cavaliere MJ, Perez NM, Russo DH, Wakamatsu A. Razzouk D: Hyperthermic reaction to haloperidol with rigidity, associated to central core disease. Acta Neurol 1994, 16:157-161
29. Kelly D, Brull SJ: Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine? Can J Anaesth 1994, 41:845-849
30. Nielsen JC, Nicholson K, Pitzner-Jorgensen BL, Unden M: Abuse of Ecstasy (3,4-methylenedioxymethamphetamine): pharmacological, neuropsychiatric and behavioral aspects. Ugeskr Laeg 1995, 157: 724-727
31. Sato N, Brum JM, Mitsumoto H, DeBoer GE: Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia. Can J Anaesth 1995, 42:158-162